- Home
- SPHR vs APGE Comparison
SPHR vs APGE Comparison
Compare SPHR & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPHR | APGE |
|---|---|---|
| Founded | 2020 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.7B |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SPHR | APGE |
|---|---|---|
| Price | $175.58 | $134.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $116.18 | $109.67 |
| AVG Volume (30 Days) | 726.4K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,220,045,000.00 | N/A |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $2.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.81 | N/A |
| 52 Week Low | $39.52 | $35.39 |
| 52 Week High | $181.63 | $134.88 |
Technical Indicators
Market Signals| Indicator | SPHR | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 76.68 |
| Support Level | $128.68 | $134.03 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 8.39 | 0.24 |
| MACD | 3.40 | -1.03 |
| Stochastic Oscillator | 87.61 | 54.12 |
Price Performance
Historical ComparisonAbout SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments: Sphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.